Your browser doesn't support javascript.
loading
Drivers of treatment patterns in patients with chronic lymphocytic leukemia stopping ibrutinib or idelalisib therapies.
Mato, Anthony R; Samp, Jennifer C; Gauthier, Geneviève; Terasawa, Emi; Brander, Danielle M.
Affiliation
  • Mato AR; a Leukemia Service, Division of Hematologic Oncology , Department of Internal Medicine, Memorial Sloan Kettering Cancer Center , New York , NY , United States.
  • Samp JC; b AbbVie, Inc. , North Chicago , IL , United States.
  • Gauthier G; c Analysis Group, Inc. , Montreal , Quebec , Canada.
  • Terasawa E; d Analysis Group, Inc. , New York , United States.
  • Brander DM; e Division of Hematologic Malignancies & Cellular Therapy, Duke University , Durham , NC , United States.
Cancer Biol Ther ; 19(7): 636-643, 2018 07 03.
Article in En | MEDLINE | ID: mdl-29584544
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purines / Pyrazoles / Pyrimidines / Leukemia, Lymphocytic, Chronic, B-Cell / Protein Kinase Inhibitors / Quinazolinones / Medication Adherence Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Biol Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2018 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purines / Pyrazoles / Pyrimidines / Leukemia, Lymphocytic, Chronic, B-Cell / Protein Kinase Inhibitors / Quinazolinones / Medication Adherence Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Biol Ther Journal subject: NEOPLASIAS / TERAPEUTICA Year: 2018 Document type: Article Affiliation country: Country of publication: